ConductScience.org, home

Gene · 412

NIH grants1,211

NIH grants whose papers are about the gene, through NIH's grant-paper links.

81 to 100 of 1,211

Download this page as JSON
GrantTitleSTS papersNewest fiscal year
P30GM133893Center for Biomolecular Structure (CBMS)12025
P41EB030006Center for Mesoscale Mapping12025
P42ES013661Iowa Superfund Research Program: Airborne PCBs: Sources, Exposures, Toxicities, Remediation12025
P42ES031007The UNC Chapel Hill Superfund Research Program (UNC-SRP)12025
P50CA116201Mayo Clinic Breast Cancer SPORE12025
P50CA127001SPORE in Brain Cancer12025
P50CA165962Targeted Therapies for Glioma12025
P50CA236733Vanderbilt-Ingram Cancer Center SPORE in Gastrointestinal Cancer12025
P50HD027802Differential Diagnosis in Learning Disabilities12025
P50HD052120Learning Disabilities Translational Science Collective: Building on the Florida LDRC12025
P50HD103555Baylor College of Medicine Intellectual and Developmental Disabilities Research Center12025
P51OD011092Support for National Primate Research Center12025
P51OD011132Emory National Primate Research Center12025
R01AA030155Inter-Enzyme Crosstalk in the Cytochrome P450 Ensemble: Implications for the Effects of Alcohol on Drug Metabolism and Alcohol-Drug Interactions12025
R01AI029564Molecular and Functional Analysis of Innate Immune Receptors12025
R01AI136621Dissecting Polyclonal Sera to Reveal Correlates of Productive Immune Responses to HIV12025
R01AR043799Mechanisms of Epidermal Homeostasis and Early Neoplasia12025
R01AR068392Genetics and Pathobiology of Disorders of Keratinization12025
R01CA072038Replication Stress and DNA Damage Response Drives ESR1 Mutant Metastasis12025
R01CA154947Defining Pathogenic Mechanisms and Therapeutic Opportunities for Langerhans Cell Histiocytosis12025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/412/grants?page=5